A phase I study to evaluate the safety, tolerability, and pharmacokinetics of HEC113995PA·H2O, a novel dual-acting serotonergic antidepressant, in healthy subjects by Xue Wu, Xue Wu, Xue Wu, Qingqing Wu, Qingqing Wu, Qingqing Wu, Qichen Ding, Qichen Ding, Qichen Ding, Yulei Zhuang, Lin Luo, Yingjun Zhang, Li Deng, Chuanfei Jin, Xue Li, Zhangma Huang, Haiping Qin, Liang Xin, Liang Xin, Liang Xin, Qian Chen, Qian Chen, Qian Chen, Jingying Jia, Jingying Jia, Jingying Jia, Yanmei Liu, Yanmei Liu, Yanmei Liu

Get full text